EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microglial reactivity predicts hippocampal, but not global, atrophy in cerebral small vessel disease

Adriana Zainurin iD, Robin B Brown, Daniel J Tozer, Hugh S Markus

Alzheimer's & Dementia · 2026-04 · 22 (4)

DOI: 10.1002/alz.71336 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 02.04.2026. Verfasst von Adriana Zainurin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Cerebral Small Vessel Diseases, Hippocampus, Microglia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council experimental medicine, National Institute for Health Research Clinical Research Network, Tun Taib Foundation scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Cerebral small vessel disease (CSVD) is the most prevalent pathology underlying vascular dementia. Increased neuroinflammation and blood‐brain barrier (BBB) permeability have been implicated in CSVD pathogenesis. We determined whether microglial reactivity and BBB permeability at baseline predicted whole‐brain and hippocampal atrophy over one year, and cognitive impairment over four years. METHODS Seventy‐seven patients with CSVD were recruited to this prospective study. Baseline microglial reactivity and BBB permeability were determined using 11 C‐PK11195 positron emission tomography and dynamic contrast enhanced (DCE) MRI respectively. RESULTS Greater 11 C‐PK11195 binding at baseline was associated with hippocampal atrophy over one year ( p = 0.001), but not with global brain atrophy. Cox regression analyses showed no significant associations between 11 C‐PK11195 and cognitive impairment. There were no associations between BBB permeability with whole‐brain and hippocampal atrophy, or with cognitive impairment. DISCUSSION Our data suggests that microglial reactivity may play a role in hippocampal atrophy; potentially contributing to the increasingly recognized interaction between vascular and neurodegenerative pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral Small Vessel DiseasesHippocampusMicrogliaHumansAtrophyFemaleMaleBlood-Brain BarrierAgedMagnetic Resonance ImagingPositron-Emission TomographyProspective StudiesCognitive DysfunctionIsoquinolines

Stichwörter der Autor:innen

MRIblood‐brain barrierdementianeuroinflammationpositron emission tomographystrokevascular cognitive impairment

Substanzen

PK 11195Isoquinolines

Autor:innen und Institutionen

  • Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

ORCID-Profile: Adriana Zainurin

Förderung

  • Medical Research Council experimental medicine
  • National Institute for Health Research Clinical Research Network
  • Tun Taib Foundation scholarship
  • the Cambridge British Heart Foundation Centre of Research Excellence
  • The Cambridge University Hospitals Biomedical Research Centre

Zitieren

APA

Zainurin, A., Brown, R. B., Tozer, D. J., & Markus, H. S. (2026). Microglial reactivity predicts hippocampal, but not global, atrophy in cerebral small vessel disease. Alzheimer's & Dementia, 22(4). https://doi.org/10.1002/alz.71336

Vancouver

Zainurin A, Brown RB, Tozer DJ, Markus HS. Microglial reactivity predicts hippocampal, but not global, atrophy in cerebral small vessel disease. Alzheimer's & Dementia. 2026;22(4). doi:10.1002/alz.71336

BibTeX
@article{Zainurin2026,
  author = {Zainurin, Adriana and Brown, Robin B and Tozer, Daniel J and Markus, Hugh S},
  title = {Microglial reactivity predicts hippocampal, but not global, atrophy in cerebral small vessel disease},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {4},
  doi = {10.1002/alz.71336}
}
Kostenlos starten →